1. Home
  2. VMRK vs IQV Comparison

VMRK vs IQV Comparison

Compare VMRK & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivmark Residential Common Shares of Beneficial Interest

VMRK

Vivmark Residential Common Shares of Beneficial Interest

N/A

Current Price

$62.12

Market Cap

48.8B

Sector

Real Estate

ML Signal

N/A

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$266.00

Market Cap

43.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VMRK
IQV
Founded
1978
1982
Country
United States
United States
Employees
N/A
93000
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8B
43.1B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
VMRK
IQV
Price
$62.12
$266.00
Analyst Decision
Buy
Strong Buy
Analyst Count
22
20
Target Price
$71.62
★ $309.76
AVG Volume (30 Days)
★ 4.1M
1.1M
Earning Date
11-04-2026
10-27-2026
Dividend Yield
★ 4.55%
N/A
EPS Growth
★ 8.09
4.67
EPS
0.54
★ 5.24
Revenue
$2,701,075,000.00
★ $9,739,000,000.00
Revenue This Year
$42.39
$7.12
Revenue Next Year
$51.23
$6.39
P/E Ratio
$114.33
★ $52.36
Revenue Growth
4.76
★ 41.60
52 Week Low
$58.64
$154.50
52 Week High
$66.45
$284.50

Technical Indicators

Market Signals
Indicator
VMRK
IQV
Relative Strength Index (RSI) 51.48 46.98
Support Level $58.64 $252.55
Resistance Level $62.26 $274.49
Average True Range (ATR) 1.08 9.53
MACD 0.17 -0.17
Stochastic Oscillator 47.55 21.45

Price Performance

Historical Comparison
VMRK
IQV

About VMRK Vivmark Residential Common Shares of Beneficial Interest

Vivmark owns a high-quality apartment portfolio with around 184,000 units and is developing another $4.4 billion of residential properties. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: